Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

Click for more information

0.00%

26.5¢ paradigm biopharmaceuticals limited..

PAR, some place in QLD and the (magical) possible pathway..., page-37

First 37 Last

Share
Profile

Follow
mattw77

109 Posts.

3

06/10/20

20:55

Post #: 47894089
Share

Originally posted by cphil1970: ↑

I can’t recommend a Dr in Melbourne....(I am in Bris)
I had the booster at 12 months, for my knee, as PR does yearly...
I imagine the phase 3 is being done in knee OA to keep the study group homogeneous, like for like. They could do it all in hip or shoulder or hands if they wanted, but you couldn’t have hips and knees and hands all in the same trial and expect to compare.
Once the phase 3 is complete, and proves (again) that Pentosan is effective in OA, then it will depend on what restrictions the PBS puts on prescribing as to how difficult it will be to prescribe off-label. Some medicines are “authority” and you need to call up the PBS and get an authority to prescribe, they need a special prescription and the patient needs to meet specific criteria. Most likely iPPS won’t be authority, and will be prescribeable for all OA (hip, knee, hands etc) The economics will be there if it prevents joint replacement.
Pentosan will work for Rheumatoid, Psoriatic Arthritis etc...as it blocks nerve growth factor, it will reduce pain no matter what process starts the arthritis....

Expand

Cphil Which Dr in Bris did you see? I am keen to talk to a Dr familiar with Zilosul.

Last edited by mattw77: 06/10/20

PAR Price at posting: $2.90 Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

What's causing the cost-of-living crisis, and how to navigate it

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

There are more pages in this discussion • 10 more messages in this thread...

First 37 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 26.5¢		Change 0.000(0.00%)		Mkt cap ! $92.81M

Open	High	Low	Value	Volume
27.0¢	29.0¢	25.5¢	$430.3K	1.585M

Buyers (Bids)

No.	Vol.	Price($)
1	5500	26.0¢

Sellers (Offers)

Price($)	Vol.	No.
26.5¢	36162	3

View Market Depth

No.	Vol.	Price($)
3	61837	0.255
2	25200	0.250
1	15000	0.245
3	85000	0.240
1	8510	0.235

Price($)	Vol.	No.
0.265	583	1
0.270	25000	1
0.275	3350	1
0.285	46000	1
0.290	44274	3

Last trade - 16.10pm 18/10/2024 (20 minute delay)

PAR (ASX) Chart